NCT02544126

Brief Summary

The purpose of this study is to investigate how working with a computer program may affect mood, feelings, overall health, and markers in blood in young adults with HIV.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2015

Shorter than P25 for not_applicable hiv

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

September 4, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 9, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

January 24, 2017

Status Verified

January 1, 2017

Enrollment Period

11 months

First QC Date

September 4, 2015

Last Update Submit

January 20, 2017

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in the Patient Health Questionnaire (PHQ-9)

    The PHQ-9 is a 9-item self-report measure of depressive symptoms which asks participants to rate the frequency of depression symptoms over the past 2 weeks from 0 (not at all) to 3 (nearly every day). Scores range from 0 to 27, with higher scores reflecting greater severity of depressive symptoms.

    Baseline, 3 months

  • Change in the General Well-Being Schedule (GWS)

    The GWS is an 18-item self-report measure that examines the subjective feelings of psychological well-being and distress which asks participants to rate each question in relationship to their feelings over the past 4 weeks on a 6-grade Likert scale. The last four items ask respondents to supply ratings on a 1-10 scale. Score range will be transformed into a the scale score on a continuum from 0 to 100, with higher scores reflecting a better well being of the participant.

    Baseline, 3 months

  • Change in Center for Disease Control Health Related Quality of Life-4 (CDC HRQOL-4)

    CDC HRQOL-4 is self-report measures quality of life over the last 30 days in the domains of physical and mental health and asks participants 4 core questions including one health status measure (self-rated health) and three HRQOL measures (recent physical health, recent mental health, and recent activity limitation). The scoring used is with a summary "unhealthy days" index, computed by adding a respondent's physically and mentally unhealthy days, with a maximum of 30 for one person.

    Baseline, 3 months

  • Change in the Quality of Life Enjoyment Scale (Q-LES-Q-SF)

    Q-LES-Q-SF is a 16 item self-report measure that assesses the quality of life satisfaction in multiple domains of functioning which asks participants to rate how satisfied they have been with various aspects of their life over the last week, rating on a 1-5 Likert-type scale. Scores range from 16 to 80, with higher scores reflecting less enjoyment and satisfaction.

    Baseline, 3 months

Secondary Outcomes (7)

  • Medication Adherence

    Baseline, 3 months

  • Change in plasma interleukin-6 (IL-6) levels

    Baseline, 3 months

  • Change in cluster of differentiation 4 (CD4) Count

    Baseline, 3 months

  • Change in Log HIV Viral Load

    Baseline, 3 months

  • Change of plasma brain-derived neurotrophic factor (BDNF) levels

    Baseline, 3 months

  • +2 more secondary outcomes

Study Arms (2)

eSMART-MH

EXPERIMENTAL

HIV+ young adults will be randomized to receive Electronic Self-Management Resource Training for Mental Health (eSMART-MH)

Device: Electronic Self-Management Resource Training for Mental Health

Attention Control

ACTIVE COMPARATOR

HIV+ young adults will be randomized to receive screen-based health education

Behavioral: Screen-based health education

Interventions

eSMART-MH is a software, which is set in a 3-D virtual primary care office environment in which a subject interacts with avatar virtual healthcare staff (medical receptionist, medical assistant, providers, and a virtual healthcare coach). The avatars are programed to behave like humans. The subject moves through the 3-D virtual primary care office and encounters virtual healthcare staff and providers. The subject practices discussing depressive symptoms with avatar healthcare providers and practices self-management skills related to symptoms of depression.The subject also interacts with the health care coach. The health care coach provides the subject with real-time strategies to enhance communication with healthcare providers during their virtual office visit. Overtime, coaching is decreased to build the the subject's self-confidence. eSMART-MH will be used once a month, for three months.

Also known as: eSMART-MH
eSMART-MH

Screen-based health education will be used and cover topics like depression, nutrition, physical activity, and sleep hygiene at the same frequency as the eSMART-MH intervention, which is used once a month, for three months.

Attention Control

Eligibility Criteria

Age23 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years of age
  • Fluent in English
  • Be able to view images and text on a computer screen and hear audio using a headset
  • Have a diagnosis of unipolar depression or have significant depressive symptoms noted in the electronic medical record (EMR) or referred to the study by a provider at the Grady Ponce de Leon Clinic because of their depressive symptoms
  • Receive care at Ponce de Leon Center and at least 1 scheduled HIV medical appointment in the last 6 months
  • Reside in the Atlanta, Georgia area
  • Have a valid telephone number and email address
  • Answer all items correctly on consent post-test

You may not qualify if:

  • Diagnosis of bipolar depression
  • Deaf, blind or unable to understand spoken English
  • Currently pregnant, history of pregnancy within the last year or plan to become pregnant within the next 4 months
  • Plan to move from the Atlanta, Georgia area within four months of study enrollment
  • Taking corticosteroids or disease-modifying anti-rheumatic drugs
  • If on antidepressant medication, taking it for less than 1 month
  • Fail to pass post-consent test after three attempt

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Melissa D Pinto, PhD,RN,FAAN

    Emory University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 4, 2015

First Posted

September 9, 2015

Study Start

September 1, 2015

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

January 24, 2017

Record last verified: 2017-01